Maven Renovar VCT Plc (MRV) Ordinary 5p
Sell:50.00p
Buy:51.00p
0
Change:
No change
No change
Market closed |
Prices as at close on 9 April 2026
Prices delayed by at least 15 minutes
|
Switch to live prices
|
- Add to watchlist
- This stock can be held in a
Sell:50.00p
Buy:51.00p
Change:
No change
No change
Deal for just £6.95 per trade in
a
Stocks and Shares ISA,
Lifetime ISA
,
SIPP
or
Fund and Share Account
Market closed |
Prices as at close on 9 April 2026
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend today
Sell:50.00p
Buy:51.00p
Change:
No change
No change
Market closed |
Prices as at close on 9 April 2026
Prices delayed by at least 15 minutes
|
Switch to live prices
|
Ex-dividend today
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.
Objective
The Company aims to achieve long-term capital gains and generate regular dividend income for its shareholders while complying with the requirements of the rules and regulations applicable to VCTs
| Security | Weight |
|---|---|
| WS Amati UK Listed Smaller Companies (Acc) | 9.89% |
| 2 Degrees Limited (Trading As Manufacture 2030) | 6.41% |
| The Property Franchise Group Plc | 5.14% |
| Craneware Plc | 4.98% |
| Northern Trust Global Funds Plc â The Sterling F | 4.30% |
| Aurrigo International Plc | 3.25% |
| Srt Marine Systems Plc | 3.11% |
| Chorus Intelligence Limited | 2.95% |
| Diaceutics Plc | 2.80% |
| Gb Group Plc | 2.73% |
Top 10 sectors currently unavailable.
| Country | Weight |
|---|---|
| United Kingdom | 9.56% |
| United States | 0.18% |
| Canada | 0.11% |
| Australia | 0.03% |
Fee Structure
The manager receives an annual fee of 1.75% of NAV, calculated and payable quarterly in arrears. The appointment may be terminated on one year notice.
Dividend Policy
The Board aims to pay annual dividends of 6% of the Company’s NAV at its immediately preceding financial year end, subject to distributable reserves, cash resources and other relevant factors such as realisations and VCT qualifying levels, and with the authority to increase or decrease this level at the Directors’ discretion.
ASSET SPLIT
Trust Manager
Not currently available for this investment trust.
Manager Bio
Not currently available for this investment trust.
Board Of Directors
Fiona WollocombeChairman, Brian Scouler, Robert Legget, Paul Jourdan, Charles McMicking, Neeta Patel, Hector Kilpatrick, Kathleen McLeay
Data policy - All information should be used for indicative purposes only. You should
independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete,
and accepts no responsibility for how it may be used.
Objective, holding data, trust manager and bio information, dividend policy, asset split and fee structure are provided by Morningstar.
The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.
Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.